ExodusPoint Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.89M | Buy |
+246,638
| New | +$8.89M | 0.08% | 240 |
|
|
2025
Q1 | – | Sell |
-143,601
| Closed | -$3.66M | – | 1805 |
|
|
2024
Q4 | $3.66M | Buy |
+143,601
| New | +$3.66M | 0.03% | 492 |
|
|
2024
Q1 | – | Sell |
-70,607
| Closed | -$1.98M | – | 1777 |
|
|
2023
Q4 | $1.98M | Sell |
70,607
-35,937
| -34% | -$1.01M | 0.01% | 537 |
|
|
2023
Q3 | $2.89M | Sell |
106,544
-378,654
| -78% | -$10.3M | 0.03% | 521 |
|
|
2023
Q2 | $14.9M | Buy |
485,198
+287,283
| +145% | +$8.83M | 0.12% | 139 |
|
|
2023
Q1 | $7.13M | Buy |
197,915
+38,951
| +25% | +$1.4M | 0.06% | 313 |
|
|
2022
Q4 | $6.28M | Buy |
158,964
+151,917
| +2,156% | +$6M | 0.09% | 283 |
|
|
2022
Q3 | $283K | Buy |
+7,047
| New | +$283K | ﹤0.01% | 1507 |
|
|
2022
Q2 | – | Sell |
-93,492
| Closed | -$3.64M | – | 2305 |
|
|
2022
Q1 | $3.64M | Buy |
+93,492
| New | +$3.64M | 0.05% | 459 |
|
|
2021
Q3 | – | Sell |
-105,724
| Closed | -$4.33M | – | 2472 |
|
|
2021
Q2 | $4.33M | Buy |
105,724
+89,128
| +537% | +$3.65M | 0.05% | 358 |
|
|
2021
Q1 | $724K | Buy |
+16,596
| New | +$724K | 0.01% | 1074 |
|
|
2020
Q4 | – | Sell |
-234,190
| Closed | -$9.85M | – | 2241 |
|
|
2020
Q3 | $9.85M | Buy |
234,190
+211,536
| +934% | +$8.9M | 0.2% | 77 |
|
|
2020
Q2 | $1.1M | Buy |
+22,654
| New | +$1.1M | 0.03% | 674 |
|